{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:06Z","timestamp":1761630366838},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T00:00:00Z","timestamp":1103155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold><jats:bold> Background:\u2002<\/jats:bold> Renal transplanted recipients have an increased incidence of actinic keratosis and skin cancer.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> In order to examine the chemoprophylatic effects of low\u2010dose acitretin on keratosis and skin cancer development we submitted 13 renal transplanted patients who presented actinic keratosis to acitretin therapy (20\u2003mg\/d) for 12\u2003months. The patients were assessed at monthly intervals during the first 6\u2003months and every 2\u2003months until the 12th month for new skin lesions and for acitretin toxicity. Normal skin biopsies of sun exposed and sun protected areas were taken for histopathological examination and submitted to immunohistochemistry technique to demonstrate CD4+ and CD8+ T lymphocytes, natural killer (NK) cells and Langerhans\u2019 cells which were counted and compared before, after 6 and 12\u2003months of the treatment.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> There was an improvement of actinic keratosis in all patients. Only one patient developed new skin cancer. Side\u2010effects were well tolerated and no significant biochemical effects were observed. There were no differences in the microscopic aspects of the skin and in the number of CD4+ and CD8+ T lymphocytes and NK cells. There was a significant increase in the number of epidermal Langerhans\u2019 cells after 12\u2003months of acitretin therapy.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> The data obtained permit us to conclude that low dose acitretin therapy is safe, well tolerated and partially effective in chemoprophylaxis of skin cancer in renal transplant recipients. The increase in epidermal Langerhans\u2019 cells observed may be an expression of the immunomodulatory effect of acitretin.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2004.00311.x","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T09:46:32Z","timestamp":1105609592000},"page":"115-121","source":"Crossref","is-referenced-by-count":26,"title":["Acitretin and skin cancer in kidney transplanted patients. Clinical and histological evaluation and immunohistochemical analysis of lymphocytes, natural killer cells and Langerhans\u2019 cells in sun exposed and sun protected skin"],"prefix":"10.1111","volume":"19","author":[{"given":"Renata V","family":"Carneiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00edrian N","family":"Sotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz S","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz E.","family":"Ianhez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evandro A","family":"Rivitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,12,16]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00075200-199806000-00001"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.6.1374"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70449-9"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.125579"},{"key":"e_1_2_10_6_2","first-page":"161","article-title":"Tumores malignos no p\u00f3s\u2010transplante renal","volume":"21","author":"Paula FJ","year":"1999","journal-title":"J Bras Nefrol"},{"key":"e_1_2_10_7_2","first-page":"459","article-title":"Decreased skin cancer after cessation of therapy with transplant\u2010associated immunosupressants","volume":"137","author":"Otley CC","year":"2001","journal-title":"Arch Dermatol"},{"key":"e_1_2_10_8_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/1523-1747.ep12536743","article-title":"Skin associated lymphoid tissue (SALT): origin and functions","volume":"80","author":"Streilein JW.","year":"1983","journal-title":"J Invest Dermatol"},{"key":"e_1_2_10_9_2","first-page":"S32","article-title":"Altera\u00e7\u00f5es na pele de pacientes portadores de insufici\u00eancia renal cr\u00f4nica em fase dial\u00edtica \u2013 um estudo morfol\u00f3gico e imuno\u2010histoqu\u00edmico","volume":"18","author":"Galv\u00e3o M","year":"1996","journal-title":"J Bras Nefrol"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70536-5"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1998.tb01686.x"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1998.tb00712.x"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.1131"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199503150-00013"},{"key":"e_1_2_10_15_2","first-page":"717","article-title":"Treatment of cutaneous neoplasia with etretinate in renal transplant recipients","volume":"68","author":"Shuttleworth D","year":"1988","journal-title":"Q J Med"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/29.4.6166661"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb02432.x"},{"key":"e_1_2_10_18_2","first-page":"255","article-title":"Use of acitretin for the skin complications in renal transplant recipients","volume":"108","author":"Yuan ZF","year":"1995","journal-title":"N Z Med J"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.8.1933"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02765.x"},{"key":"e_1_2_10_21_2","first-page":"737","article-title":"Acitr\u00e9tine","volume":"128","author":"Berbis PH.","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70058-6"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1998.00433.x"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70446-3"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199805150-00022"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb03223.x"},{"key":"e_1_2_10_27_2","first-page":"349","article-title":"Anti\u2010cancer actions of retinoids","volume":"42","author":"Medawar PB","year":"1981","journal-title":"Immunology"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70447-5"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12338626"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1995.tb02960.x"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00412884"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1981.tb01709.x"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02612.x"},{"key":"e_1_2_10_34_2","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1182\/blood.V84.12.4107.bloodjournal84124107","article-title":"Retinoids (all\u2010trans and 9\u2010cis retinoic acid) stimulate production of macrophage colony\u2010stimulating factor and granulocyte\u2010macrophage colony\u2010stimulating factor by human bone marrow stromal cells","volume":"84","author":"Nakajima H","year":"1994","journal-title":"Blood"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2004.00311.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2004.00311.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T01:06:48Z","timestamp":1696900008000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2004.00311.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,16]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1111\/j.1399-0012.2004.00311.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2004.00311.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,16]]}}}